Lexicon Pharmaceuticals
LXRX
#8721
Rank
$0.13 B
Marketcap
$0.37
Share price
2.66%
Change (1 day)
-85.22%
Change (1 year)

P/E ratio for Lexicon Pharmaceuticals (LXRX)

P/E ratio as of March 2025 (TTM): -0.5381

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.538088. At the end of 2022 the company had a P/E ratio of -3.13.

P/E ratio history for Lexicon Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-3.13-51.52%
2021-6.463.87%
2020-6.22-282.8%
20193.40-158.91%
2018-5.77-28.7%
2017-8.10-19.78%
2016-10.1-96.21%
2015-2665602.54%
2014-4.67-48.13%
2013-9.00-10.41%
2012-10.0172.55%
2011-3.69-10.42%
2010-4.1140.37%
2009-2.9317.24%
2008-2.50-49.67%
2007-4.9711.45%
2006-4.46-30.4%
2005-6.40-38.94%
2004-10.5102.96%
2003-5.1724.52%
2002-4.15-74.83%
2001-16.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-0.0465-91.35%๐Ÿ‡บ๐Ÿ‡ธ USA
17.7-3,398.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.86 617.42%๐Ÿ‡บ๐Ÿ‡ธ USA
89.5-16,737.71%๐Ÿ‡บ๐Ÿ‡ธ USA
33.9-6,397.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.5337-0.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.21 497.41%๐Ÿ‡บ๐Ÿ‡ธ USA
68.0-12,736.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-20.3 3,678.81%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.